The Investment Committee designated by the Romanian Government for the Recovery Equity Fund has approved financing for five new investment funds in Q4 2025, announced the Ministry of Investments and European Projects (MIPE).
Wonderful, the enterprise agent platform builder, announced a $100 million Series A funding round on November 11. The round was led by Index Ventures, with participation from Insight Partners and IVP, alongside existing investors Bessemer and Vine Ventures.
Medicai, a local health-tech startup specializing in cloud-native medical imaging, is expanding its presence in the US market, backed by an investment of approximately €200,000.
GapMinder Fund II announced a €2 million seed investment in Salestools AI, supporting the company's vision to automate and enhance B2B sales processes through autonomous digital agents.
The InvestALIM program, designed to support the development of the food industry, will provide funding for 12 projects with a total investment value of over €300 million.
The BeeFast SaaS platform provides real-time visibility of delivery operations through an intuitive dispatcher tailored to the specific requirements of instant deliveries.
Norofert, the Romanian producer of organic agricultural inputs and biotechnology provider, has started a share capital increase to raise up to RON 9 million (€1.8 million) following approval from the Financial Supervisory Authority.
Romania recorded the lowest rate of generative artificial intelligence (AI) adoption among young people in the European Union in 2025, according to data released by Eurostat.
Romania's trade deficit decreased by €673 million to €32.7 billion in 2025, representing a 2% improvement compared to 2024, according to data published by the National Institute of Statistics (INS).
Romania's Ministry of Finance has announced the adoption of a Formal Opinion by the Organisation for Economic Co-operation and Development (OECD) Committee on Fiscal Affairs, following the country's evaluation as part of its accession process to the OECD.